Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Lewis

Showing results (71-80 of 359) with videos related to

Pageof 36
Sort By:
Biorxiv : the Preprint Server for Biology|January 30, 2023
Radiances of Cerenkov-Emitting Isotopes on the IVISEdwin C Pratt, Travis M Shaffer, David Bauer, et al.
Chemical Communications (Cambridge, England)|January 12, 2019
Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell linesNatalia Curado, Guillaume Dewaele-Le Roi, Sophie Poty, et al.
Nuclear Medicine and Biology|July 2, 2011
The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancerBrian M Zeglis, NagaVaraKishore Pillarsetty, Vadim Divilov, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2025
Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging SystemEdwin C Pratt, Travis M Shaffer, David Bauer, et al.
The Journal of Biological Chemistry|September 5, 2025
Activity-based probes and chemical proteomics uncover the biological impact of targeting HMGCS1 in the mevalonate pathwaySang Ah Yi, Liang Sun, Yi Rao, et al.
Dalton Transactions (Cambridge, England : 2003)|October 10, 2013
H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177LuEric W Price, Brian M Zeglis, Jason S Lewis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 17, 2018
α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 1Sophie Poty, Lynn C Francesconi, Michael R McDevitt, et al.
Molecular Imaging and Biology|September 10, 2020
ImmunoPET Imaging of Pancreatic Tumors with <sup>89</sup>Zr-Labeled Gold Nanoparticle-Antibody ConjugatesNicholas B Sobol, Joshua A Korsen, Ali Younes, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Activity-based probes and chemical proteomics uncover the biological impact of targeting HMGCS1Sang Ah Yi, Liang Sun, Yi Rao, et al.
Theranostics|June 3, 2020
<sup>89</sup>Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinomaSophie Poty, Komal Mandleywala, Edward O'Neill, et al.
Pageof 36

Showing results (71-80 of 359) with videos related to

Sort By:
Pageof 36
Biorxiv : the Preprint Server for Biology|January 30, 2023
Radiances of Cerenkov-Emitting Isotopes on the IVISEdwin C Pratt, Travis M Shaffer, David Bauer, et al.
Chemical Communications (Cambridge, England)|January 12, 2019
Trastuzumab gold-conjugates: synthetic approach and in vitro evaluation of anticancer activities in breast cancer cell linesNatalia Curado, Guillaume Dewaele-Le Roi, Sophie Poty, et al.
Nuclear Medicine and Biology|July 2, 2011
The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancerBrian M Zeglis, NagaVaraKishore Pillarsetty, Vadim Divilov, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2025
Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging SystemEdwin C Pratt, Travis M Shaffer, David Bauer, et al.
The Journal of Biological Chemistry|September 5, 2025
Activity-based probes and chemical proteomics uncover the biological impact of targeting HMGCS1 in the mevalonate pathwaySang Ah Yi, Liang Sun, Yi Rao, et al.
Dalton Transactions (Cambridge, England : 2003)|October 10, 2013
H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177LuEric W Price, Brian M Zeglis, Jason S Lewis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 17, 2018
α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies-Part 1Sophie Poty, Lynn C Francesconi, Michael R McDevitt, et al.
Molecular Imaging and Biology|September 10, 2020
ImmunoPET Imaging of Pancreatic Tumors with <sup>89</sup>Zr-Labeled Gold Nanoparticle-Antibody ConjugatesNicholas B Sobol, Joshua A Korsen, Ali Younes, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2025
Activity-based probes and chemical proteomics uncover the biological impact of targeting HMGCS1Sang Ah Yi, Liang Sun, Yi Rao, et al.
Theranostics|June 3, 2020
<sup>89</sup>Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinomaSophie Poty, Komal Mandleywala, Edward O'Neill, et al.
Pageof 36